Literature DB >> 16956362

The medical management of prostate cancer: a multidisciplinary team approach.

Cora N Sternberg1, Michael Krainer, William K Oh, Sergio Bracarda, Joaquim Bellmunt, Haluk Ozen, Alexandre Zlotta, Tomasz M Beer, Stephane Oudard, Michael Rauchenwald, Iwona Skoneczna, Markus M Borner, John M Fitzpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16956362     DOI： 10.1111/j.1464-410X.2006.06477.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  12 in total

1.  Urologists' attitudes regarding information sharing with prostate cancer patients--is there a common ground for collaboration with family physicians?

Authors:  Orit Cohen Castel; Mordechai Alperin; Lea Ungar; Ina Kravtsov; Gilad E Amiel; Khaled Karkabi
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

2.  [Interdisciplinary treatment of urological tumors: a mixed-method study].

Authors:  S Beermann; L Weißbach
Journal:  Urologe A       Date:  2012-08       Impact factor: 0.639

3.  [Therapy of castration-resistant prostate cancer].

Authors:  Michael Rauchenwald; Thomas Bauernhofer; Maria De Santis; Thorsten Füreder; Wolfgang Höltl; Gero Kramer; Steffen Krause; Wolfgang Loidl; Renée Oismüller; Andreas Reissigl; Nikolaus Schmeller; Walter Stackl; Franz Stoiber; Michael Krainer
Journal:  Wien Klin Wochenschr       Date:  2012-07-20       Impact factor: 1.704

4.  Quality assessment in prostate cancer centers certified by the German Cancer Society.

Authors:  Christoph Kowalski; Julia Ferencz; Peter Albers; Jan Fichtner; Thomas Wiegel; Günter Feick; Simone Wesselmann
Journal:  World J Urol       Date:  2015-09-21       Impact factor: 4.226

5.  Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial.

Authors:  Paul C M S Verhagen; Mark F Wildhagen; Annet M Verkerk; Egils Vjaters; Hembo Pagi; Leonhard Kukk; Dejan Bratus; Richard Fiala; Chris H Bangma; Fritz H Schröder; Gerald H J Mickisch
Journal:  World J Urol       Date:  2013-11-21       Impact factor: 4.226

6.  [Role of chemotherapy in castration-resistant prostate cancer: are there new approaches?].

Authors:  M De Santis; M Bachner
Journal:  Urologe A       Date:  2012-01       Impact factor: 0.639

7.  Predictive modelling in hormone-refractory prostate cancer (HRPC).

Authors:  J Bellmunt; J Carles; J Albanell
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

8.  [Chemotherapy for prostate cancer].

Authors:  Michael Rauchenwald; Maria De Santis; Eleonore Fink; Wolfgang Höltl; Gero Kramer; Isabella-Carolina Marei; Hans-Jörg Neumann; Andreas Reissigl; Nikolaus Schmeller; Walter Stackl; Alfred Hobisch; Michael Krainer
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 9.  [Urology in the concept of comprehensive cancer centers].

Authors:  B Hadaschik; S Pahernik; C Grüllich; H Sültmann; D Jäger; C von Kalle; S Duensing; M Hohenfellner
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

10.  Current Patterns of Management of Advanced Prostate Cancer in Routine Clinical Practice in Spain.

Authors:  Maria José Ribal; Juan Ignacio Martínez-Salamanca; Camilo García Freire
Journal:  Prostate Cancer       Date:  2015-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.